We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




RNA Assay Kit Launched for Histological Tissue Samples

By LabMedica International staff writers
Posted on 08 Sep 2010
A robust and standardized manual assay in ready-to-use format can detect ribonucleic acid (RNA) biomarkers in routine formalin-fixed, paraffin-embedded (FFPE) tissue specimens.

The assay profiles single cell gene expression in situ, unlocking the full potential of RNA biomarkers. More...
The targeted molecular signature of every cell in a sample is revealed and measured precisely, all within the intricate cellular and tissue architecture of clinical specimens. The in situ assay has single molecule sensitivity and it can be completed in six hours.

The kit, known as the RNAscope FFPE Assay Kit, demonstrated polymerase chain reaction (PCR)-level sensitivity and specificity, detecting an RNA biomarker in all samples deemed positive by real time reverse transcriptase PCR, but not in samples deemed negative. In contrast, using a traditional nonisotopic in situ hybridization (ISH), the biomarker was only detected in the highest expressing sample. Since the PCR-positive samples showed two orders of magnitude difference in expression levels, RNAscope is as much as 100-fold more sensitive than the traditional nonisotopic ISH method. It does not require any expensive instrument and the staining results can be stored as archival and can be visualized and interpreted under a bright field microscope.

RNAscope is manufactured by Advanced Cell Diagnostics, Inc (Hayward, CA, USA). The products are intended to be used by translational clinical scientists studying biomarkers in disease tissues and exploring their potential for diagnostic applications. Yuling Luo, Ph.D., President and CEO of the company, said, "Over the last several decades, immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) technologies have been developed to detect proteins and DNA in situ, respectively. But reliable detection of RNA in situ remains difficult, especially in routine clinical specimens. The scientific community is being offered an 'IHC-like' tool for RNA that has the sensitivity and specificity rivaling that of PCR."

RNAscope multiplex technology has the sensitivity to detect every gene in the human transcriptome in situ, and to quantify simultaneously multiple mRNA transcripts at a single cell level. While RNAscope is designated as research use only product at the moment, the company is developing fully automated, proprietary diagnostic tests for personalized cancer treatment. The company is also partnering with pharmaceutical and biotechnology companies to leverage its RNAscope platform for companion diagnostic applications.

Related Links:
Advanced Cell Diagnostics



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Electrolyte Analyzer
BKE-B
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.